Search

everythinglearnresearchcommunity

for

Search:↓

The cause of post-finasteride syndrome is unclear and needs more research.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Effective hair loss treatment requires personalized approaches and patient-provider collaboration.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Platelet-rich plasma, microneedling with minoxidil, and topical finasteride are promising treatments for hair loss.

Topical minoxidil and oral finasteride and dutasteride are the most effective treatments for male and female pattern hair loss, but study quality varies.

Male hair loss is mainly due to thinner hair, not less hair.

Combination therapy for hair loss can improve results and reduce side effects.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Experts recommend specific treatments like minoxidil and finasteride for managing hereditary hair loss.

New treatments for common hair loss include medications, regenerative therapies, and laser therapy, but may not work for everyone.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

In Spain, dermatologists most commonly prescribe topical minoxidil and oral finasteride for male hair loss, and topical minoxidil and oral contraceptives for female hair loss. The use of oral dutasteride and oral minoxidil has significantly increased over the past three years.

Low-dose oral minoxidil effectively treats mild-moderate male hair loss, alone or combined with other therapies.

Minoxidil and finasteride are FDA-approved treatments for male hair loss, but off-label use of oral minoxidil, dutasteride, and higher doses of finasteride and minoxidil is increasing.

Dermatologists in Spain now mostly prescribe oral minoxidil and dutasteride for hair loss.

A new minoxidil regimen improved hair loss in a lupus patient.

Conventional treatments like dutasteride and minoxidil are effective for male hair loss, with some alternative treatments also showing promise.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Ethanol boosts brain steroid production by activating NMDA receptors, affecting memory formation.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Finasteride and minoxidil work best together for hair loss.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Hair loss treatments work better with lifestyle changes.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.